Effects of the cholinesterase inhibitor donepezil on organic and functional deficits associated with age-related decrease of growth hormone
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Donepezil (Primary)
- Indications Alzheimer's disease
- Focus Pharmacodynamics
- 12 Aug 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 07 Aug 2009 Biomarkers information updated
- 07 Jul 2008 The expected completion date for this trial is now 1 Jul 2009 as reported by ClinicalTrials.gov